Copy number and targeted mutational analysis reveals novel somatic events in metastatic prostate tumors C.M. Robbins, W.A. Tembe, A. Baker, S. Sinari, T. Y. Moses, S. Beckstrom-Sternberg, J. Beckstrom-Sternberg, M. Barrett, J. Long, A. Chinnaiyan, J. Lowey, E. Suh, J.V. Pearson, D.W.
Mark Dronsfield appointed Director of Sales, Europe LEXINGTON, Mass – December 7, 2010 – RainDance Technologies, Inc., a private company pioneering microdroplet-based technologies for single molecule and single cell analysis, today announced the latest addition to its worldwide commer
Museum of Science, Boston and the Boston Patent Law Association honor company’s contributions to advancing genetic research LEXINGTON, Mass – December 1, 2010 – RainDance Technologies, Inc., a private company pioneering microdroplet-based technologies for single molecule and single ce
RainDance Technologies® is making complex genetics simple. The company’s ultra-sensitive genomic tools enable research of novel non-invasive liquid biopsy applications that should result in more accurate, reliable, cost-effective, and early detection of cancer and other inherited and infectious diseases. Major research institutions and laboratories around the world rely on the performance of RainDance systems. Based outside Boston, Massachusetts, the company supports customers using RainDrop® Digital PCR, as well as the ThunderStorm® and ThunderBolts™ Next-Generation Sequencing Enrichment Systems through its international sales and service operations, as well as a global network of distributors and commercial service providers. Both technology platforms have been recognized by The Scientist as Top 10 Innovations with the RainDrop System winning the award in 2014 and the ThunderStorm System winning the award in 2011.